It wasn't a collapse, but it was a classic fluorochemical squeeze. TANFAC Industries — the Anupam Rasayan-JV that owns the niche for Anhydrous Hydrofluoric Acid (AHF) and other fluorine specialties — just delivered a quarter that looks strong on the top line and weak where it matters.
Q1 FY27 Snapshot:
* Revenue: Rs 188.03 Cr, jumped 6.26% YoY from Rs 176.95 Cr in Q1 FY26
* Net Profit: Rs 16.85 Cr, fell -12.92% YoY from Rs 19.35 Cr- reported elsewhere as down 13% from Rs 19.4 crore
* Margin: Net profit margin fell to 8.96%, PAT margin moderated to 9% from 11% in Q1 FY26
On a sequential basis, the picture is worse: revenue fell -2.87% QoQ and net profit fell -6.6% QoQ.
So why does a 13% decline rank among India's notable misses? Because it tells the whole story of the Indian fluorine chain in 2025-26.
#### 1. Why Tanfac Missed: The Old Input Cost Story
TANFAC’s total expenditure increased 7.86% year-on-year to Rs. 164.27 crore during the quarter. Raw material consumption rose 13.26% to Rs. 126.80 crore due to increased international sulphur prices, while power and fuel expenses surged nearly 30% to Rs. 16.65 crore amid higher energy costs.
Profit before tax declined 3.63% year-on-year to Rs. 23.75 crore, while EBITDA declined 1.3% to Rs 28.6 crore from Rs 29 crore, and EBITDA margin narrowed to 15.3% from 16.4%.
This is the classic Tanfac problem: Revenue growth is driven by higher offtake of Solar Grade DHF and specialty grades, but AHF is extremely power and sulphur intensive. When those two spike, margins compress instantly.
For context, full-year FY26 already showed this disconnect: Tanfac posted net sales of ₹711.07 crores, up 27.89% over FY25, but full-year net profit declined 20.30% from ₹88.00 crores.
#### 2. Ranking the Miss: Where Does -13% Sit in India's Fluorochemical Scorecard?
The Indian fluorine sector is notorious for earnings volatility because of R-22, R-32 refrigerant price cycles and export exposure. Tanfac's miss is notable, but not the worst.
Ranking India's Recent Notable Fluorochemical Earnings Misses:
#1. Navin Fluorine International - EPS Miss 20% (2024)
The gold standard of a miss. Navin Fluorine missed earnings with ₹5.2b revenue coming in 9.2% below analyst models, and statutory EPS of ₹10.32 fell short by 20%.
#2. Gujarat Fluorochemicals - EPS Miss 11% (FY23-24 cycle)
GFL shareholders were disappointed when statutory earnings per share came in 11% below what analysts expected, at ₹39.60 per share. In another quarter, revenue fell 4.9% short of estimates at ₹47b, and EPS missed forecasts by 3.6%.
#3. TANFAC Q1 FY27 - Profit Decline 12.92% / 13%
Tanfac's -12.92% YoY decline ranks right in the middle. It's not a forecast miss of 20%, but it's a margin-led earnings miss driven by input costs, not demand. That makes it structurally more concerning than a one-off volume miss.
#4. SRF Ltd - Cyclical Downcycle (2023-24)
SRF, with revenue of Rs 109,060.9 m vs Tanfac's much smaller scale, saw extended de-growth in chemicals as R-32 realizations crashed. Every $1 per kg change in R32 can swing SRF EBITDA by ₹260 crore.
#5. Gujarat Fluorochemicals - Peer Group Underperformance
Despite being the largest R-22 producer in India, GFL has also seen analyst cuts as every $1/kg move in R32 impacts earnings by ₹77 crore for Navin.
#### 3. What Makes Tanfac Different?
Three things separate Tanfac from SRF / Navin / GFL:
1. No refrigerant cushion: Tanfac is pure upstream - AHF, KF, NaF. It doesn't benefit when R-32 prices spike like SRF and Navin do.
2. Power intensity: That 30% surge in power & fuel is killer. The Cuddalore plant is now investing in efficiency, but it's still exposed to Tamil Nadu grid costs.
3. Capex overhang: Tanfac just completed a Rs.250 crore QIP to fund its HFC-32 refrigerant gas project, on track for Q3 FY27. The company achieved net debt-free status this quarter, but until HFC-32 starts, you have interest cost with no revenue.
Bottom line: A 13.4% decline isn't a disaster - revenue is still growing at 6.3% YoY on strong Solar Grade DHF demand. But in a sector where a $1 move in R-32 can make or break a quarter, Tanfac's earnings show how even India's most specialized fluorine player can't escape sulphur and power inflation.
If Q2 sulphur prices stay elevated, expect Tanfac to remain in the Top 5 earnings misses list for FY27.